Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant
Conditions
- COPD
- Emphysema
- Alpha-1 Antitrypsan Deficiency
Interventions
- OTHER: placebo
- DRUG: basiliximab
Sponsor
University Health Network, Toronto
Collaborators